Natural products from the termite Nasutitermes corniger lowers aminoglycoside minimum inhibitory concentrations

Henrique D M Coutinho1, Alexandre Vasconcellos, Hilzeth L Freire-Pessôa

  • 1Laboratório de Pesquisa em Produtos Naturais, Departamento de Ciências Biológicas, Universidade Regional do Cariri, Crato (CE), 63105-000, Brazil.

Insights

Natural products from Nasutitermes corniger nests show promise in combating antibiotic resistance. The termite nest extract, combined with certain antibiotics, demonstrated synergistic effects, suggesting a new approach against resistant bacteria.

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Pharmacology

Background:

  • Bacterial infections pose significant public health risks, leading to high morbidity and mortality.
  • Antibiotic resistance is a growing threat, driven by the overuse of antimicrobial drugs.
  • Natural products are explored for novel therapeutic applications against resistant pathogens.

Purpose of the Study:

  • To investigate the antibacterial and antibiotic-modifying activities of Nasutitermes corniger nest extract.
  • To evaluate the potential of natural products in overcoming bacterial resistance mechanisms, particularly efflux systems.
  • To explore synergistic interactions between Nasutitermes corniger compounds and existing antibiotics.

Main Methods:

  • Preparation of aqueous extract from Nasutitermes corniger (ANCE) nest.
  • Microdilution and checkerboard methods were employed to determine antimicrobial activity and synergism.
  • Testing of ANCE and chlorpromazine (CPZ) in combination with aminoglycosides against resistant Escherichia coli.

Main Results:

  • ANCE exhibited low intrinsic antibacterial activity (MIC/MBC >/= 2048 µg/mL).
  • Synergistic effects were observed between ANCE and kanamycin.
  • Chlorpromazine (CPZ) showed synergism with kanamycin, amikacin, and neomycin, indicating efflux pump involvement.

Conclusions:

  • Nasutitermes corniger natural products, particularly with kanamycin, offer potential for modifying antibiotic activity.
  • Chlorpromazine's synergistic effects highlight the role of efflux systems in aminoglycoside resistance.
  • Zoo-derived natural products from N. corniger present a novel strategy against antibiotic-resistant bacteria.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...